Efficacy of Eco-Friendly Toothpaste Tablets Versus Conventional Toothpaste Using PI and GI Index

February 3, 2025 updated by: Loma Linda University

Objectives: To assess the change in gingival index (GI) and plaque index (PI) when comparing the use of toothpaste tablets to conventional toothpaste.

Methods: 40 participants were randomized into two groups: Colgate's toothpaste tablets (T) and Colgate's Cavity Protection toothpaste (C). Both groups utilized their assigned dentifrice for 2 weeks. A pre and post-assessment measured the GI and PI index. A questionnaire on the use of the product was distributed.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Loma Linda, California, United States, 92350
        • Loma Linda University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Subjects are 18 years or older;
  2. Subjects who will comply with study protocol;
  3. Subjects who can read and understand the consent form;
  4. Subjects available during the study period;
  5. Subjects have more than 20 teeth.

Exclusion Criteria:

  1. Subjects who are pregnant and/or nursing;
  2. Subjects under the age of 18.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Toothpaste Tablet
Subjects are instructed to use one toothpaste tablet for brushing. Brushing is recommended twice daily for two minutes.
Colgate Anywhere Toothpaste Tablets
Active Comparator: Conventional Toothpaste
Subjects are instructed to use the toothpaste for brushing. Brushing is recommended twice daily for two minutes.
Colgate Cavity Protection

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plaque Index Score at Baseline
Time Frame: Change between baseline at visit 1 and visit 2, two weeks post baseline.

Plaque was scored according to the Turesky modification of the Quigley-Hein Plaque Index. Each tooth was divided into six surfaces, three facial and three lingual, as follows: 1) mesio-facial; 2) mid-facial; 3) disto-facial; 4) mesio-lingual; 5) mid-lingual; and 6) disto-lingual. Teeth included in the scoring were: #3, 7, 12, 19, 23, 28. Plaque was disclosed and scored on each tooth surface according to the following criteria:

0: No plaque.

  1. Separate flecks of plaque at the cervical margin.
  2. A thin, continuous band of plaque (up to 1 mm) at the cer- vical margin.
  3. A band of plaque wider than 1 mm but covering less than 1/3 of the side of the crown of the tooth.
  4. Plaque covering at least 1/3, but less than 2/3 of the side of the crown of the tooth.
  5. Plaque covering 2/3 or more of the side of the crown of the tooth.

Subject-wise scores were determined by averaging the values obtained over all scorable surfaces in the mouth.

Change between baseline at visit 1 and visit 2, two weeks post baseline.
Gingival Index Score at Baseline
Time Frame: Change between baseline at visit 1 and visit 2, two weeks post baseline.

Gingivitis was scored according to the Löe-Silness Gingival Index. Each tooth was divided into six surfaces, three facial and three lingual, as follows: 1) mesio-facial; 2) mid-facial; 3) disto-facial; 4) mesio-lingual; 5) mid-lingual; and 6) disto-lingual. Teeth included in the scoring were: #3, 7, 12, 19, 23, 28. The gingiva adjacent to each tooth surface was scored as follows:

0 = Absence of inflammation.

  1. = Mild inflammation-slight change in color and little change in texture.
  2. = Moderate inflammation-moderate glazing, redness, edema, and hypertrophy.
  3. = Severe inflammation-marked redness and hypertrophy. Tendency for spontaneous bleeding.

Subject-wise scores were determined by averaging the values obtained over all scorable surfaces in the mouth.

Change between baseline at visit 1 and visit 2, two weeks post baseline.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subject Perception of Product Use
Time Frame: Visit 2 two weeks post study enrollment
This is a composite measurement based on questionnaire response. Subjects will answer 7 questions related to cleanliness, flavor, ease of use, eco-friendliness, willingness to switch, satisfaction, texture. This is measured on a Likert Scale from 1-4. 1 represents strongly agree with overall product satisfaction. 4 represents strongly disagree with overall product satisfaction.
Visit 2 two weeks post study enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: So Ran Kwon, DDS, MS, PhD, Loma Linda University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 3, 2023

Primary Completion (Actual)

January 23, 2023

Study Completion (Actual)

January 23, 2023

Study Registration Dates

First Submitted

March 28, 2023

First Submitted That Met QC Criteria

March 28, 2023

First Posted (Actual)

April 10, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 3, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gingival Inflammation

Clinical Trials on Toothpaste Tablet

Subscribe